Related Funds
Fund Name | Location |
Alderville Holding | - |
Canada media fund | Canada, Ontario, Toronto |
Chunxin Zhangying Investment | China, Ningbo, Zhejiang |
Credit Suisse Entrepreneur Capital | - |
Dcode | District of Columbia, United States, Washington |
Grupo Wiese | Lima, Lima, Peru |
Incofin Investment Management | Antwerp, Antwerpen, Belgium |
Kings Park Capital | England, London, United Kingdom |
Luye Pharma | China, Shanghai |
Mencey Capital | - |
Pittiglio, Rabin, Todd, & McGrath (PRTM) | Massachusetts, United States, Waltham |
Pritzker Foundation | - |
Sequoia Capital (SSF) | - |
Shiji Huaxing Touzi | Beijing, Beijing, China |
Simple Tech Investment (STI) | Hanoi, Vietnam |
Southeast Interactive Technology Funds | Morrisville, North Carolina, United States |
Staples | Framingham, Massachusetts, United States |
Valence Capital Management | New York, New York, United States |
Vestian | - |
Wuhan Baifuqin Real Estate | China, Hubei, Wuhan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MiRXES Pte Ltd | $87M | 22 Feb 2022 | Singapore, Central, Singapore | ||
inyad | $8M | 01 Oct 2021 | Casablanca, Grand Casablanca, Morocco | ||
Visen Pharmaceuticals | $150M | 08 Jan 2021 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
MiRXES Pte Ltd | $87M | 22 Feb 2022 | Singapore, Central, Singapore | ||
inyad | $8M | 01 Oct 2021 | Casablanca, Grand Casablanca, Morocco | ||
Visen Pharmaceuticals | $150M | 08 Jan 2021 | Shanghai, China |